Dr. Noah Ivers: WCH’s new chair in implementation science
Dr. Noah Ivers
Dr. Noah Ivers, a leader in implementation science, has been appointed as a joint hospital and university chair in this emerging field. He will be leveraging the support of the chair, in collaboration with the University of Toronto’s department of family and community medicine, to enable his internationally recognized research program to design, test and evaluate evidence-based, patient-centered interventions to improve care quality, especially when it comes to reducing the risk and impact of women’s cancers.
Implementation science is a multidisciplinary field that strives to improve population health by studying different methods and strategies to promote the uptake of interventions that have been proven to work in routine, daily practice.
Dr. Ivers will bring to this role insights from the world of research, innovation and front-line healthcare delivery. He is currently a scientist at Women's College Research Institute (WCRI), an innovation fellow at Women’s College Hospital Institute for Health System Solutions and Virtual Care (WIHV) and an adjunct scientist at ICES. At Women's College Hospital (WCH), he is also a family physician and assistant professor in the department of family and community medicine at the University of Toronto.
Dr. Ruth Heisey, medical director at the Peter Gilgan Centre for Women’s Cancers says, “Welcoming Dr. Ivers’ expertise in this area will be pivotal to the work of the centre. He will help us reach women who are now at risk or who are living with cancer in many parts of the country.”
Working alongside the Canadian Cancer Society, a spread and scale lead and other health system partners, Dr. Ivers will be identifying some of the most promising interventions that push the envelope in women’s cancer care, and then scaling them up at other care sites across Canada. He will also be a catalyst for multidisciplinary collaborations between researchers at WCH and the University of Toronto in support for this effort.
“We are pleased to congratulate Dr. Ivers on this outstanding achievement,” adds Dr. Paula Rochon, vice-president, research at WCH. “His reputation for rigorous, applied research and strong relationships with collaborators around the world make him ideally suited to this role, particularly in supporting our institutional goal of revolutionizing health for women."
The Peter Gilgan Centre for Women’s Cancers at Women College Hospital, in collaboration with the Canadian Cancer Society, draws together excellence in research, clinical care, innovation and education for women’s cancers.